Prevention of propofol injection pain: Comparison between lidocaine and ramosetron

Background: Propofol causes a high incidence of pain during intravenous (IV) injection. The aim of this randomized, placebo-controlled, double-blinded study was to determine whether pre-treatment with IV ramosetron, used for prophylaxis of postoperative nausea and vomiting (PONV), would reduce propo...

Full description

Bibliographic Details
Main Authors: Dipali Singh, Sathyanarayan Jagannath, Shio Priye, Shivaprakash, Chandrashekar Kadli, Durgaprasad Reddy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Journal of Anaesthesiology Clinical Pharmacology
Subjects:
Online Access:http://www.joacp.org/article.asp?issn=0970-9185;year=2014;volume=30;issue=2;spage=213;epage=216;aulast=Singh
id doaj-1f3c8fa9483d4901b6a1390c361275c4
record_format Article
spelling doaj-1f3c8fa9483d4901b6a1390c361275c42020-11-24T21:15:35ZengWolters Kluwer Medknow PublicationsJournal of Anaesthesiology Clinical Pharmacology0970-91852014-01-0130221321610.4103/0970-9185.130023Prevention of propofol injection pain: Comparison between lidocaine and ramosetronDipali SinghSathyanarayan JagannathShio PriyeShivaprakashChandrashekar KadliDurgaprasad ReddyBackground: Propofol causes a high incidence of pain during intravenous (IV) injection. The aim of this randomized, placebo-controlled, double-blinded study was to determine whether pre-treatment with IV ramosetron, used for prophylaxis of postoperative nausea and vomiting (PONV), would reduce propofol-induced pain as an equivalent to lidocaine. Materials and Methods: Hundred and twenty American Society of Anesthesiologists grade (ASA) I and II patients were randomly assigned into three groups (40 in each). Group N received 2 ml of 0.9% saline, Group L received 2 ml of lidocaine, and Group R received 2 ml of ramosetron. Mid forearm was occluded manually before injection and released after 1 min and then propofol was injected over 5 s. Patients were observed and questioned 15 s later if they had pain in the arm and pain was scored on a four-point scale: 0 = no pain, 1 = mild pain, 2 = moderate pain, and 3 = severe pain. Unpaired Student′s t-test and chi-square test/Fisher′ exact test were used to analyze results. Results: The incidence of pain in groups N, L, and R were 65, 35, and 30%, respectively. Pain was reduced significantly in the groups L and R (P < 0.05). Two patients each in Groups L and R (5% each) had moderate and severe pain. This difference in pain was statistically insignificant, but when compared to Group N (25 and 30%, respectively) it was statistically significant. Conclusion: Pretreatment with ramosetron 0.3 mg and lidocaine 40 mg are equally effective in preventing pain from propofol injection.http://www.joacp.org/article.asp?issn=0970-9185;year=2014;volume=30;issue=2;spage=213;epage=216;aulast=SinghInjectionlidocainepainpropofolramosetron
collection DOAJ
language English
format Article
sources DOAJ
author Dipali Singh
Sathyanarayan Jagannath
Shio Priye
Shivaprakash
Chandrashekar Kadli
Durgaprasad Reddy
spellingShingle Dipali Singh
Sathyanarayan Jagannath
Shio Priye
Shivaprakash
Chandrashekar Kadli
Durgaprasad Reddy
Prevention of propofol injection pain: Comparison between lidocaine and ramosetron
Journal of Anaesthesiology Clinical Pharmacology
Injection
lidocaine
pain
propofol
ramosetron
author_facet Dipali Singh
Sathyanarayan Jagannath
Shio Priye
Shivaprakash
Chandrashekar Kadli
Durgaprasad Reddy
author_sort Dipali Singh
title Prevention of propofol injection pain: Comparison between lidocaine and ramosetron
title_short Prevention of propofol injection pain: Comparison between lidocaine and ramosetron
title_full Prevention of propofol injection pain: Comparison between lidocaine and ramosetron
title_fullStr Prevention of propofol injection pain: Comparison between lidocaine and ramosetron
title_full_unstemmed Prevention of propofol injection pain: Comparison between lidocaine and ramosetron
title_sort prevention of propofol injection pain: comparison between lidocaine and ramosetron
publisher Wolters Kluwer Medknow Publications
series Journal of Anaesthesiology Clinical Pharmacology
issn 0970-9185
publishDate 2014-01-01
description Background: Propofol causes a high incidence of pain during intravenous (IV) injection. The aim of this randomized, placebo-controlled, double-blinded study was to determine whether pre-treatment with IV ramosetron, used for prophylaxis of postoperative nausea and vomiting (PONV), would reduce propofol-induced pain as an equivalent to lidocaine. Materials and Methods: Hundred and twenty American Society of Anesthesiologists grade (ASA) I and II patients were randomly assigned into three groups (40 in each). Group N received 2 ml of 0.9% saline, Group L received 2 ml of lidocaine, and Group R received 2 ml of ramosetron. Mid forearm was occluded manually before injection and released after 1 min and then propofol was injected over 5 s. Patients were observed and questioned 15 s later if they had pain in the arm and pain was scored on a four-point scale: 0 = no pain, 1 = mild pain, 2 = moderate pain, and 3 = severe pain. Unpaired Student′s t-test and chi-square test/Fisher′ exact test were used to analyze results. Results: The incidence of pain in groups N, L, and R were 65, 35, and 30%, respectively. Pain was reduced significantly in the groups L and R (P < 0.05). Two patients each in Groups L and R (5% each) had moderate and severe pain. This difference in pain was statistically insignificant, but when compared to Group N (25 and 30%, respectively) it was statistically significant. Conclusion: Pretreatment with ramosetron 0.3 mg and lidocaine 40 mg are equally effective in preventing pain from propofol injection.
topic Injection
lidocaine
pain
propofol
ramosetron
url http://www.joacp.org/article.asp?issn=0970-9185;year=2014;volume=30;issue=2;spage=213;epage=216;aulast=Singh
work_keys_str_mv AT dipalisingh preventionofpropofolinjectionpaincomparisonbetweenlidocaineandramosetron
AT sathyanarayanjagannath preventionofpropofolinjectionpaincomparisonbetweenlidocaineandramosetron
AT shiopriye preventionofpropofolinjectionpaincomparisonbetweenlidocaineandramosetron
AT shivaprakash preventionofpropofolinjectionpaincomparisonbetweenlidocaineandramosetron
AT chandrashekarkadli preventionofpropofolinjectionpaincomparisonbetweenlidocaineandramosetron
AT durgaprasadreddy preventionofpropofolinjectionpaincomparisonbetweenlidocaineandramosetron
_version_ 1716744694218620928